Together with the enhanced secretion of neo-antigens from dying tumor cells, activated DCs promote the activation of CD4+ and CD8+ T cells, monocytes and macrophages [241,242,243], rendering the pro-tumorigenic TME into a more anti-tumorigenic TME. The gene discussed is CD8A; the disease is neoplasm.